Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.45 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6352310 | 0.91 | APEX1 (0.52) | ALBHTTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6352320 | 0.84 | TAS2R14 (0.57) | ALBTAS2R14ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6352988 | 0.84 | TAS2R14 (0.56) | ALBTAS2R14ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6359090 | 0.83 | ALB (0.53) | ALBHTTTAS2R14ALDH1A1LMNA | |
| SCHEMBL6359077 | 0.83 | ALB (0.56) | ALBHTTTAS2R14ALDH1A1LMNA | |
| SCHEMBL6352388 | 0.82 | ALB (0.51) | ALBALDH1A1LMNASMN1; SMN2KMT2A | |
| SCHEMBL6818482 | 0.81 | HTT (0.39) | ALBHTTTAS2R14OPRK1ALDH1A1 | |
| SCHEMBL6350364 | 0.80 | ALB (0.51) | ALBTAS2R14ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6359027 | 0.79 | ALB (0.50) | ALBTAS2R14ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6353693 | 0.78 | ALB (0.55) | ALBHTTALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | ALB 1682/4885HTT 2677/4885TAS2R14 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.